Intrust Bank’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $954K | Sell |
4,249
-391
| -8% | -$97.4K | 0.08% | 173 |
|
|
2025
Q4 | $1.12M | Sell |
4,640
-219
| -5% | -$56K | 0.09% | 152 |
|
|
2025
Q3 | $1.33M | Sell |
4,859
-62
| -1% | -$16.9K | 0.11% | 132 |
|
|
2025
Q2 | $1.27M | Sell |
4,921
-793
| -14% | -$189K | 0.11% | 136 |
|
|
2025
Q1 | $1.28M | Buy |
5,714
+214
| +4% | +$50K | 0.13% | 127 |
|
|
2024
Q4 | $1.26M | Buy |
5,500
+122
| +2% | +$29.4K | 0.13% | 127 |
|
|
2024
Q3 | $1.31M | Buy |
5,378
+152
| +3% | +$34K | 0.13% | 125 |
|
|
2024
Q2 | $1M | Sell |
5,226
-231
| -4% | -$46.9K | 0.11% | 148 |
|
|
2024
Q1 | $1.08M | Sell |
5,457
-238
| -4% | -$43.6K | 0.12% | 143 |
|
|
2023
Q4 | $980K | Buy |
5,695
+132
| +2% | +$20.3K | 0.11% | 146 |
|
|
2023
Q3 | $823K | Sell |
5,563
-1,148
| -17% | -$208K | 0.1% | 158 |
|
|
2023
Q2 | $1.47M | Buy |
6,711
+59
| +0.9% | +$13.2K | 0.18% | 104 |
|
|
2023
Q1 | $1.46M | Sell |
6,652
-170
| -2% | -$36.9K | 0.19% | 108 |
|
|
2022
Q4 | $1.42M | Sell |
6,822
-94
| -1% | -$20.7K | 0.2% | 97 |
|
|
2022
Q3 | $1.51M | Buy |
6,916
+65
| +0.9% | +$14.8K | 0.23% | 82 |
|
|
2022
Q2 | $1.44M | Sell |
6,851
-672
| -9% | -$143K | 0.21% | 93 |
|
|
2022
Q1 | $1.82M | Buy |
7,523
+383
| +5% | +$92.6K | 0.23% | 85 |
|
|
2021
Q4 | $1.86M | Sell |
7,140
-147
| -2% | -$38.1K | 0.22% | 87 |
|
|
2021
Q3 | $1.92M | Sell |
7,287
-190
| -3% | -$52K | 0.25% | 80 |
|
|
2021
Q2 | $1.84M | Sell |
7,477
-97
| -1% | -$20.4K | 0.25% | 82 |
|
|
2021
Q1 | $1.47M | Buy |
7,574
+142
| +2% | +$28.5K | 0.21% | 92 |
|
|
2020
Q4 | $1.58M | Buy |
7,432
+184
| +3% | +$36.7K | 0.24% | 86 |
|
|
2020
Q3 | $1.24M | Sell |
7,248
-30
| -0.4% | -$5.54K | 0.22% | 92 |
|
|
2020
Q2 | $1.4M | Sell |
7,278
-254
| -3% | -$41.6K | 0.28% | 79 |
|
|
2020
Q1 | $1.11M | Buy |
7,532
+102
| +1% | +$16.2K | 0.31% | 75 |
|
|
2019
Q4 | $1.15M | Buy |
7,430
+55
| +0.7% | +$7.93K | 0.26% | 93 |
|
|
2019
Q3 | $997K | Sell |
7,375
-303
| -4% | -$39.7K | 0.25% | 97 |
|
|
2019
Q2 | $937K | Sell |
7,678
-948
| -11% | -$105K | 0.23% | 107 |
|
|
2019
Q1 | $897K | Sell |
8,626
-330
| -4% | -$34.1K | 0.23% | 112 |
|
|
2018
Q4 | $1.02M | Buy |
8,956
+326
| +4% | +$34.9K | 0.3% | 74 |
|
|
2018
Q3 | $996K | Buy |
8,630
+759
| +10% | +$83.1K | 0.25% | 91 |
|
|
2018
Q2 | $815K | Buy |
7,871
+626
| +9% | +$63.3K | 0.23% | 113 |
|
|
2018
Q1 | $713K | Sell |
7,245
-209
| -3% | -$19.8K | 0.21% | 127 |
|
|
2017
Q4 | $631K | Buy |
7,454
+124
| +2% | +$10.2K | 0.19% | 151 |
|
|
2017
Q3 | $564K | Sell |
7,330
-95
| -1% | -$7.27K | 0.18% | 166 |
|
|
2017
Q2 | $579K | Buy |
7,425
+324
| +5% | +$23.2K | 0.2% | 151 |
|
|
2017
Q1 | $511K | Buy |
7,101
+73
| +1% | +$5.04K | 0.18% | 167 |
|
|
2016
Q4 | $436K | Buy |
7,028
+729
| +12% | +$44.6K | 0.17% | 194 |
|
|
2016
Q3 | $408K | Buy |
6,299
+144
| +2% | +$9.59K | 0.16% | 207 |
|
|
2016
Q2 | $389K | Buy |
+6,155
| New | +$363K | 0.16% | 205 |
|
Other funds holding RMD
VCM
VPM
DAM
Intrust Bank's RMD Position: Q1 2026 in Review
Intrust Bank reduced its ResMed (RMD) stake by 8.4% in Q1 2026, selling an estimated $97.4K and leaving 4,249 shares worth $954K. The position accounts for 0.08% of the portfolio, ranked #173.
Intrust Bank first reported a position in RMD in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.92M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Intrust Bank held 4,249 shares of ResMed worth $954K as of Q1 2026.
- Intrust Bank sold 391 ResMed shares in Q1 2026, an estimated $97.4K.
- ResMed made up 0.08% of Intrust Bank's portfolio in Q1 2026, its #173 holding.
- Intrust Bank first reported a position in ResMed in Q2 2016 and has held it in 40 quarters since.
- Intrust Bank's ResMed position peaked at $1.92M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.